Purpose: The Emergency Department (ED) is an important venue for the care of patients with cancer. We sought to describe the national characteristics of ED visits by patients with cancer in the United States. Methods: We performed an analysis of 2012-2014 ED visit data from the National Hospital Ambulatory Medical Care Survey (NHAMCS). We included adult (age ≥ 18 years) ED patients, stratified by history of cancer. Using the NHAMCS survey design and weighting variables, we estimated the annual number of adult ED visits by patients with cancer. We compared demographics, clinical characteristics, ED resource utilization, and disposition of cancer vs. non-cancer patients. Results: There were an estimated 104,836,398 annual ED visits. Patients with cancer accounted for an estimated 3,879,665 (95% CI: 3,416,435-4,342,895) annual ED visits. Compared with other ED patients, those with cancer were older (mean 64.8 vs. 45.4 years), more likely to arrive by Emergency Medical Services (28.0 vs. 16.9%), and experienced longer lengths of ED stay (mean 4.9 vs. 3.8 h). Over 65% of ED patients with cancer underwent radiologic imaging. Patients with cancer almost twice as likely to undergo CT scanning; four times more likely to present with sepsis; twice as likely to present with thrombosis, and three times more likely to be admitted to the hospital than non-cancer patients. Conclusions: Patients with cancer comprise nearly 4 million ED visits annually. The findings highlight the important role of the ED in cancer care and need for addressing acute care conditions in patients with cancer.
Introduction
Cancer is the second leading cause of death after heart disease in the United States [1] . In 2018, there will be an estimated 1,735,350 new cases of cancer in the United States (US), with an estimated 609,640 deaths due to cancer [1] . It is projected that by year 2020 the national cost of cancer care will be $173 billion [2] . In addition, the overall incidence rate of new cancer cases is also expected to increase between 2010 and 2030 [3] .
The Emergency Department (ED) is an important venue for the care of patients with cancer. Patients with cancer often develop conditions requiring emergency care such as fever, infection, dehydration, intractable nausea and vomiting, weakness, dyspnea and systemic reactions to therapeutic agents [4] [5] [6] [7] . Cancer is also often identified during the ED care of other acute conditions [8] [9] [10] . Despite its importance in cancer care, there are currently few reports of ED utilization by patients with cancer in the United States (US) [11] . Prior studies have been limited to smaller population samples, single EDs, or EDs outside the US [12] [13] [14] . An improved understanding of the characteristics of patients with cancer presenting to US EDs could enhance the care provided to and outcomes of this important population.
We sought to determine the national characteristics, processes of care, and outcomes of patients with cancer presenting to the ED in the US.
Methods

Study design
We used data from the National Hospital Ambulatory Medical Care Survey (NHAMCS) [15] . This study was exempted from review requirements by the Institutional Review Board of the University of Alabama at Birmingham due to the de-identified, publicly-available nature of the data set.
Data source
Managed by the National Center for Health Statistics (NCHS), NHAMCS is a national probability sample of outpatient and ED hospital visits across the US [15] . The survey uses a four-stage probability design to sample geographical areas, hospitals within these areas, emergency service areas within the EDs of these hospitals, and patient visits to these emergency service areas. NHAMCS examines ED visits to selected facilities for a defined four-week period to identify clinical data from all identified records. The clinical information collected varies by survey year but generally includes patient demographics, vital signs, ED tests and treatments, and ED disposition and outcome. Surveys from 2012 and 2013 included up to three primary diagnoses, and surveys from 2014 included up to five diagnoses.
For this study, we used the 2012-2014 NHAMCS public-use data set, which encompassed a period with uniform reporting of cancer status, medications given in the ED, and selected patient demographics needed for the planned analysis.
Selection of subjects
We included ED visits by adults over 18 years old. We stratified the analysis by patient cancer status, identified using the NHAMCS variable "cancer status." NHAMCS defined cancer status as any type of cancer, including carcinoma, sarcoma, leukemia, and lymphoma. The NHAMCS definition excluded a history of cancer in remission or that had been cured.
ED visit characteristics
We examined demographic characteristics including patient age, sex, race, and ethnicity. Clinical characteristics included mode of arrival, triage vital signs, length of visit, fever, and mean pain scale. Following prior convention, we defined fever as a temperature of ≥100.4°F or ≤96.8°F [16] . We identified diagnostic imaging performed in the ED, including computed tomography, magnetic resonance imaging, ultrasound, and X-ray imaging. We classified ED medications using drug class identification codes specified by the NCHS (Lexicon Plus, Cerner Multum, Inc., Kansas City, MO, USA).
For the ED visit diagnoses, data abstractors identified the three (year 2012 and 2013) or five (year 2014) most prominent documented diagnoses for each ED visit. We grouped primary ED diagnoses by major International Classification of Diseases, ninth edition (ICD-9) categories. In addition, because of their relevance to cancer, we identified primary ED diagnoses for respiratory, abdominal/pelvic and digestive symptoms, signs and conditions, as well as thrombosis and sepsis. We identified thrombotic events through the ICD-9 codes 415.0-415. 19 [16] . We also identified select NHAMCS reasons for ED visits, focusing on complaints relevant to cancer, including abdominal pain, nausea/vomiting, chest pain, and shortness of breath.
ED disposition categories included discharge home, admission to hospital, transfer to another hospital, and other/unknown (e.g., not reported, died in ED, or left against medical advice). Admission destinations included non-ICU, ICU, and other/unknown.
Data analysis
We determined the annual number of ED visits for individuals with cancer. We compared demographic, clinical and disposition characteristics between patients with and without cancer. We annualized all frequency estimates. We used the NHAMCS sampling design and weight variables to provide nationally-weighted estimates with 95% confidence intervals (CIs). We performed Rao-Scott corrected chi-square tests of association and adjusted Wald F-tests of equal means to compare categorical and continuous variables, respectively [17] . For all analyses, we used ultimate cluster design variables ("masked" stratum and primary sampling unit identifiers from the NHAMCS data set) with single stage sampling in standard error calculations; prior studies have demonstrated that these estimation methods are conservative. Results based upon b30 raw observations or standard error values N30% relative to the estimate are considered unreliable by the NCHS, so we noted table cells not fulfilling this threshold. All analyses were performed using Stata 14.1 (StataCorp LLC, College Station, TX, USA).
Results
In ED patients with cancer were older than patients without cancer (mean 64.8 vs. 45.4 years). ED patients with cancer were more likely to be white and non-Hispanic (Table 1) . Patients with cancer were more likely to arrive to the ED by EMS (28.0 vs. 16.9%; p b 0.001). Patients with cancer presented with higher triage pulse and respiratory rate and lower systolic blood pressure than patients without cancer. Patients with cancer were more likely to present to the ED with a fever. Pain scales were lower for patients with cancer. Patients with cancer also experienced longer lengths of ED stay (mean 4.9 vs. 3.8 h).
Over 65% of ED patients with cancer underwent radiologic imaging. Patients with cancer were more likely to undergo head, chest and abdomen CT scans (27.7 vs. 17.7%; p b 0.001) and X-rays (47.8 vs. 34.1%; p b 0.001) ( Table 2 ). The most common medications administered for ED patients with cancer included CNS agents, respiratory agents, nutritional products, and gastrointestinal (GI) agents (Table 3) . ED patients with cancer were more likely to receive anti-infective agents, cardiovascular agents, CNS agents, coagulation modifiers, GI agents, nutritional products, respiratory agents, and metabolic agents. Among CNS agents, the most common medications were analgesics and antiemetics. Bronchodilators and antihistamines were the most common respiratory agents.
Patients with cancer exhibited a range of primary ED diagnoses (Table 4) . Common oncology-related reasons for ED visit were abdominal pain, nausea and vomiting, chest pain, and shortness of breath. Compared with non-cancer patients, patients with cancer were four times more likely to present with sepsis (2.1% vs. 0.5%; p b 0.001) and twice as likely to present with a thrombotic event (0.8% vs. 0.4%; p = 0.02). ED patients with cancer were more than two times more likely to be admitted to the hospital than non-cancer patients (28.8 vs. 10.7%; p-value b 0.001) ( Table 5) . Among admitted patients, rates of intensive care unit admission were similar between patients with and without cancer (14.2 vs. 12.6%; p-value = 0.41).
Discussion
Cancer is one of the most prominent healthcare conditions in the US. The ED is a recognized arena for cancer diagnosis and care. Our results affirm the enormous national burden of patients with cancer upon US EDs. Patients with cancer comprised almost 4 million ED visits annually, presented with higher acuity than other patients, were large users of ED resources, and experienced longer ED length of stay. Almost 30% of ED patients with cancer were admitted to the hospital.
Prior studies of ED use by patients with cancer have notable limitations. Yucel et al. and Sadil et al. characterized ED visits by patients with cancer in Turkey, but these series were relatively limited (n = 336 and 408) and may not apply to the US setting [12, 13] . Vandyk et al. performed a meta-analysis of ED visits related to cancer treatment or cancer-related symptoms but focused on symptoms reported by patients [18] . Mayer et al. described 37,760 ED visits by patients with cancer in North Carolina [14] . Our study has notable strengths over these prior studies, using the most currently available data to providing one of the first nationally representative descriptions of ED visits by patients with cancer in the US. We were also able to illuminate processes of ED care and ED outcomes among these individuals.
Rivera et al. estimated US ED visits of cancer diagnosed patients and presented clinical utilization patterns between 2006 and 2012 from the Nationwide Emergency Department Sample [19] . There are important but complementary distinctions between the Rivera study and our current work. Rivera et al. estimated 2.5 million annual ED visits by cancer patients, while we estimated 3.9 million annual ED visits. Rivera et al. were able to discern cancer types, finding that breast, prostate and lung cancer were the most commonly diagnosed cancers with ED visits. The most common reasons for ED visits in the Rivera study were pneumonia (4.5%), nonspecific chest pain (3.7%), and urinary tract infection (3.2%), while in our study abdominal pain, nausea and vomiting, chest pain, and shortness of breath were common conditions. While Rivera et al. observed higher admission rates than in our study (59.7% vs. 28.8%), they could not ascertain intensive care unit admission rates, which we found to be similar between cancer and non-cancer patients. Finally, we were able to provide additional key information about cancer patient ED visits not available in the National Emergency Department Sample, including physiologic findings (vital signs), use of radiological tests, and administered medications.
Emergency medicine textbooks highlight important principles in the ED evaluation and care of patients with cancer [20] . Our observations largely affirm these beliefs and practices. For example, patients with cancer are thought to be more susceptible to infections and thrombotic event; we found that patients with cancer were almost four times more likely to present with sepsis and almost twice as likely to present with a thrombotic event [21] [22] [23] [24] . Nausea, vomiting and dehydration are common side-effects of chemotherapy; our results affirm the frequent ED use of intravenous fluids and antiemetics among patients with cancer [25] . We observed an approximately 30% hospital admission rate among ED patients with cancer, which is lower than in prior studies [14, 18] . Mayer et al. reported a 63.2% admission rate for patients with cancer but included cases based upon cancer-related ICD-9 codes, which may have selected a higher-acuity population [14] . A tempting question is whether there may be opportunities for mitigating ED visits by patients with cancer. The Centers for Medicare and Medicaid Services (CMS) novel Oncology Care Model advocates the delivery of higher quality, more highly coordinated oncology care at the same or lower cost to Medicare [26] . In addition, the National Cancer Institute has advocated scientific efforts to better understand the utilization of the ED for cancer care, application of clinical strategies to improve the outcomes of patients utilizing the ED, and efforts to reduce ED use by patients with cancer [27] . However, we underscore that while our paper illuminates the national epidemiology of ED use by patients with cancer, our results cannot be used to estimate the number of avoidable ED visits in this population. For example, while cancer-related pain and vomiting are often perceived as symptoms that may be ameliorated in the outpatient setting, the severity of these cases varies widely, with many cases meriting treatment in the emergency setting. Other conditions such as sepsis and thromboembolic disease clearly merit evaluation and treatment in the ED, regardless of perceived severity.
The large presence of patients with cancer in the ED may indicate an opportunity for better integrating the ED into the continuum of cancer care. Emergency physicians are accustomed to rapid patient evaluation and risk stratification, provision of appropriate initial treatment (including critical care), and the identification of the most appropriate care destination. The ED plays a pivotal role in the care of a range of acute conditions such as myocardial infarction, stroke, sepsis and trauma. These principles can potentially apply to the care of patients with cancer. While additional granular data may identify subsets of patients with cancer that could receive emergency care in alternate settings, the opportunity and potential system gains could be limited. Larger advances may result from organized systemic efforts to better integrate the ED into spectrum of cancer care. Examples of integrating strategies include providing education on the contemporary issues in oncologic emergencies, definition of diagnostic and treatment protocols for patients with cancer presenting to the ED, and aligned decision making with oncology teams when determining admission vs. discharge. Furthermore, risk stratification tools used by the ED (for example, the Pneumonia Severity Index, or the Pulmonary Embolism Rule-Out Criteria score) must be updated to account for the presence of cancer, which may alter the predictive of these decision rules [28, 29] .
Limitations
The most important limitation of these data is the inability to differentiate the types or stages of cancer exhibited by each patient. The NHAMCS cancer definition was designed to identify individuals undergoing treatment for active cancer, but the reliability of chart abstraction for this measure has not been tested. We did not use hospital or ED diagnoses to identify cancer status. We also could not link to cancer treatment regimens. While we identified the high use of ED diagnostic and therapeutic resources, we could not evaluate the utility or appropriateness of these measures. We also could not link to longterm outcomes. Prospective studies are needed to answer these and other important questions regarding the ED care of patients with cancer. Nonetheless, our study represents one of the first national perspectives of ED use by cancer patients in the US. NHAMCS uses a retrospective, probability-sampled design and coding may be inconsistent or incomplete. Abstractors also may not have been consistent in the identification or coding of cancer in the medical record. We were also unable to determine whether ED visits represented re-visits by the same person. Laboratory values were not available. Only triage vital signs were available -repeat physiologic measures were not available. Data on certain processes of ED care such as volume of fluid resuscitation were not available. We did not have data on hospital inpatient course.
Conclusions
Patients with cancer comprise a significant portion of US Emergency Department visits, with almost 4 million visits estimated each year. These observations underscore the importance of the ED in the care of patients with cancer. Complications following abortion and ectopic and molar pregnancies 646. 6 Infections of genitourinary tract in pregnancy 658. 4 Infection of amniotic cavity 670
Major puerperal infection 675. 
